The ANSI/ISA-95 standard defines models for the information flows between the instrumentation and automation layers up to the enterprise information layers for process manufacturers and producers. Moving up the levels increases the need for people, processes and...
The Emerson Exchange conference October 6-10 in Orlando, Florida USA is rapidly approaching. I caught up with Emerson's Michalle Adkins who mentioned that her team of Life Sciences consultants would be highlighting the enablement of release by exception. Although...
Author: Michalle Adkins I often get asked, "So, what do you do for a living?" Boy is that a loaded question. When I say that I manage a group of Life Sciences Industry Consultants for Emerson—that really does not help to answer the question. Hmmm, how do I describe...
Author: Gary Mitchell The Emerson Life Sciences Industry Solutions Group consultants, including Saroj Patnaik, Michalle Adkins, Jonathan Lustri, Zuwei Jin and me, will be joining Hillary Clinton, Sir Richard Branson and over 15,000 other attendees from Biotech and...
Pharmaceutical and biotech manufacturing processes are complex and require well integrated and documented flows of information from upfront forecast demand and customer orders through the production process to inventory receipt and order fulfillment. The components...
For many process manufacturers with lean engineering staffs, partnering with outside automation specialists is critical for successful automation and optimization projects. Emerson's Michalle Adkins, who leads the Life Sciences Industry Solutions consulting team,...
In an earlier post, Five Strategies for Mitigating Automation Project Risk, we highlighted the importance of prototyping: Risks in budget, schedule, changes, and project execution can be reduced with a prototyping strategy. Prototyping helps incorporate operational...
The ISA-95 (IEC 62264) Enterprise-Control System Integration (part 1, part 2, part 3, part 4, part 5) international standard provides a model to help define the boundaries between the enterprise systems and process control systems. As manufacturing operations seek to...
If you're in the pharmaceutical and biotech industries, you likely know that Interphex takes place today through Thursday at the Javits Center in New York City. On Wednesday at 1:30-2:30pm in 1E10, Emerson's Michalle Adkins will be leading a panel, Road Map to...
I wanted to share my guest post over at the PharmaEvolution.com blog, Justifying New Tech Investment When the Plant Is Running Full Out. It can often be challenging to justify investing in new technology when a plant has spare capacity, as Michalle Adkins mentioned...
Justifications for automation investments can be based on many factors—increasing revenues, reducing costs, increasing working capital efficiency, and maximizing the return on fixed capital. How do you justify automation investments from a production process not...
I recently saw an interesting discussion about the use of consultants. One question that came up was why they seem to ask the same question in slightly different ways or the same question to different functional groups in an organization. Emerson's Michalle Adkins, a...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.